Welcome To Investor Watch

In this series will be going over trials, research and other clinical verticals that receive funding. Below are the ones we cover in this episode:

  • Texas-Based CPRIT Allocates $21M to Texas-based Cancer Investigators & Venture
  • NeoTX Therapeutics Secures $45m to Conduct Phase I Clinical Trial leveraging the Proprietary Selective T Cell Redirection (STR) Platform
  • Solving Rising Behavioral Health Challenges with Virtual Reality? Oxford University Spinoff Raises $12.5m
  • Short Sellers Pursue Principia Biopharma Arguing the Addressing Autoimmune Disease with BTK Inhibitors Flawed Strategy
  • Disease with BTK Inhibitors Flawed Strategy

Pin It on Pinterest